Wu C, Zhang Z, Zhang W, Liu X. Mitochondrial dysfunction and mitochondrial therapies in heart failure. Pharmacol Res. 2022;175:106038.

Article  CAS  PubMed  Google Scholar 

Metra M, Teerlink JR. Heart failure. Lancet. 2017;390(10106):1981–95.

Article  PubMed  Google Scholar 

Dunlay SM, Roger VL, Redfield MM. Epidemiology of heart failure with preserved ejection fraction. Nat Reviews Cardiol. 2017;14(10):591–602.

Article  Google Scholar 

Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al. Heart Disease and Stroke Statistics-2018 update: a Report from the American Heart Association. Circulation. 2018;137(12):e67–492.

Article  PubMed  Google Scholar 

Tang WHW, Li DY, Hazen SL. Dietary metabolism, the gut microbiome, and heart failure. Nat Reviews Cardiol. 2019;16(3):137–54.

Article  CAS  Google Scholar 

Cui X, Ye L, Li J, Jin L, Wang W, Li S, et al. Metagenomic and metabolomic analyses unveil dysbiosis of gut microbiota in chronic heart failure patients. Sci Rep. 2018;8(1):635.

Article  PubMed  PubMed Central  Google Scholar 

Pasini E, Aquilani R, Testa C, Baiardi P, Angioletti S, Boschi F, et al. Pathogenic gut Flora in patients with Chronic Heart failure. JACC Heart Fail. 2016;4(3):220–7.

Article  PubMed  Google Scholar 

Li L, Zhong S, Cheng B, Qiu H, Hu Z. Cross-talk between gut microbiota and the heart: a new target for the herbal medicine treatment of heart failure? Evidence-based complementary and alternative medicine. eCAM. 2020;2020:9097821.

PubMed  PubMed Central  Google Scholar 

Kamo T, Akazawa H, Suda W, Saga-Kamo A, Shimizu Y, Yagi H, et al. Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure. PLoS ONE. 2017;12(3):e0174099.

Article  PubMed  PubMed Central  Google Scholar 

Zhang Y, Wang Y, Ke B, Du J. TMAO: how gut microbiota contributes to heart failure. Transl Res. 2021;228:109–25.

Article  CAS  PubMed  Google Scholar 

Heianza Y, Ma W, Manson JE, Rexrode KM, Qi L. Gut microbiota metabolites and risk of major adverse Cardiovascular Disease events and death: a systematic review and Meta-analysis of prospective studies. J Am Heart Assoc. 2017;6(7).

Organ CL, Otsuka H, Bhushan S, Wang Z, Bradley J, Trivedi R, et al. Choline Diet and its gut microbe-derived metabolite, trimethylamine N-Oxide, exacerbate pressure overload-Induced Heart failure. Circulation Heart Fail. 2016;9(1):e002314.

Article  CAS  Google Scholar 

Suzuki T, Yazaki Y, Voors AA, Jones DJL, Chan DCS, Anker SD, et al. Association with outcomes and response to treatment of trimethylamine N-oxide in heart failure: results from BIOSTAT-CHF. Eur J Heart Fail. 2019;21(7):877–86.

Article  CAS  PubMed  Google Scholar 

Wang Y, Wang Q, Li C, Lu L, Zhang Q, Zhu R, et al. A review of Chinese herbal medicine for the treatment of chronic heart failure. Curr Pharm Design. 2017;23(34):5115–24.

CAS  Google Scholar 

Jia Q, Wang L, Zhang X, Ding Y, Li H, Yang Y, et al. Prevention and treatment of chronic heart failure through traditional Chinese medicine: role of the gut microbiota. Pharmacol Res. 2020;151:104552.

Article  CAS  PubMed  Google Scholar 

Xu L, Chen L, Gu G, Wang Y, Xu Y, Zhong Y. Natural products from traditional Chinese medicine for the prevention and treatment of heart failure: progress and perspectives. Rev Cardiovasc Med. 2022;23(2):60.

Article  PubMed  Google Scholar 

Cui H, Han S, Dai Y, Xie W, Zheng R, Sun Y, et al. Gut microbiota and integrative traditional Chinese and western medicine in prevention and treatment of heart failure. Phytomedicine. 2023;117:154885.

Article  PubMed  Google Scholar 

Lyu M, Wang YF, Fan GW, Wang XY, Xu SY, Zhu Y. Balancing Herbal Medicine and Functional Food for Prevention and Treatment of Cardiometabolic Diseases through modulating gut microbiota. Front Microbiol. 2017;8:2146.

Article  PubMed  PubMed Central  Google Scholar 

Wang S, Ye L, Wang L. Protective mechanism of shenmai on myocardial ischemia-reperfusion through the energy metabolism pathway. Am J Translational Res. 2019;11(7):4046–62.

CAS  Google Scholar 

Ye LF, Zheng YR, Wang LH. Effects of Shenmai injection and its bioactive components following ischemia/reperfusion in cardiomyocytes. Experimental Therapeutic Med. 2015;10(4):1348–54.

Article  CAS  Google Scholar 

Li L, Li J, Wang Q, Zhao X, Yang D, Niu L, et al. Shenmai Injection protects against Doxorubicin-Induced Cardiotoxicity via maintaining mitochondrial homeostasis. Front Pharmacol. 2020;11:815.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang X, Lv S, Zhang W, Jia Q, Wang L, Ding Y, et al. Shenmai injection improves doxorubicin cardiotoxicity via miR-30a/Beclin 1. Volume 139. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie; 2021. p. 111582.

Mei SL, Xia ZY, Qiu Z, Jia YF, Zhou JJ, Zhou B. Shenmai Injection attenuates myocardial Ischemia/Reperfusion Injury by Targeting Nrf2/GPX4 signalling-mediated ferroptosis. Chin J Integr Med. 2022;28(11):983–91.

Article  CAS  PubMed  Google Scholar 

Wang SM, Ye LF, Wang LH. Shenmai Injection Improves Energy Metabolism in patients with heart failure: a Randomized Controlled Trial. Front Pharmacol. 2020;11:459.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu SY, Zhou Y, Zhong SJ, Yang M, Huang SM, Li L, et al. Shenmai Injection improves Hypertensive Heart failure by inhibiting myocardial fibrosis via TGF-β 1/Smad pathway regulation. Chin J Integr Med. 2023;29(2):119–26.

Article  CAS  PubMed  Google Scholar 

Cheng H, Liu J, Zhang D, Wang J, Tan Y, Feng W, et al. Ginsenoside Rg1 alleviates Acute Ulcerative Colitis by modulating gut microbiota and Microbial Tryptophan Metabolism. Front Immunol. 2022;13:817600.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bai X, Duan Z, Deng J, Zhang Z, Fu R, Zhu C et al. Ginsenoside Rh4 inhibits colorectal cancer via the modulation of gut microbiota-mediated bile acid metabolism. J Adv Res. 2024. S2090-1232(24)00265-0.

Li L, Zhong SJ, Hu SY, Cheng B, Qiu H, Hu ZX. Changes of gut microbiome composition and metabolites associated with hypertensive heart failure rats. BMC Microbiol. 2021;21(1):141.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu YP, Zhang S, Xin YF, Gu LQ, Xu XZ, Zhang CD, et al. Evidences for the mechanism of Shenmai injection antagonizing doxorubicin-induced cardiotoxicity. Phytomedicine. 2021;88:153597.

Article  CAS  PubMed  Google Scholar 

Wu J, Ye X, Yang S, Yu H, Zhong L, Gong Q. Systems Pharmacology Study of the Anti-liver Injury mechanism of Citri Reticulatae Pericarpium. Front Pharmacol. 2021;12:618846.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen X, Wang X, Ma L, Fang S, Li J, Boadi EO, et al. The network pharmacology integrated with pharmacokinetics to clarify the pharmacological mechanism of absorbed components from Viticis Fructus extract. J Ethnopharmacol. 2021;278:114336.

Article  CAS  PubMed  Google Scholar 

Li F, Wu X, Liu H, Liu M, Yue Z, Wu Z et al. Copper depletion strongly enhances ferroptosis via mitochondrial perturbation and reduction in antioxidative mechanisms. Antioxid (Basel). 2022;11(11).

Shi Y, Du Q, Li Z, Xue L, Jia Q, Zheng T, et al. Multiomics profiling of the therapeutic effect of Dan-deng-tong-nao capsule on cerebral ischemia-reperfusion injury. Phytomedicine. 2024;128:155335.

Article  CAS  PubMed  Google Scholar 

Slaats J, Ten Oever J, van de Veerdonk FL, Netea MG. IL-1β/IL-6/CRP and IL-18/ferritin: distinct inflammatory programs in infections. PLoS Pathog. 2016;12(12):e1005973.

Article  PubMed  PubMed Central  Google Scholar 

Jiang J, Qi L, Lv Z, Jin S, Wei X, Shi F. Dietary stevioside supplementation alleviates lipopolysaccharide-induced intestinal mucosal damage through anti-inflammatory and antioxidant effects in broiler chickens. Antioxidants. 2019;8(12):575.

Article  CAS  PubMed  PubMed Central